Stockreport

Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA =1 by Week Six [Yahoo! Finance]

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK April 1, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) , a clinical-stage biopharmaceutical company, today announced positive clinical results fr [Read more]